Reversal of Ventricular Remodeling With Toprol-XL

PHASE3CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

August 31, 2001

Primary Completion Date

September 30, 2003

Study Completion Date

September 30, 2003

Conditions
Heart Failure, Congestive
Interventions
DRUG

Seloken ZOK/Toprol-XL

50 mg

DRUG

Seloken ZOK/Toprol-XL

200 mg

DRUG

Placebo

Trial Locations (44)

Unknown

Birmingham

Mobile

Little Rock

Los Angeles

Northridge

Redondo Beach

Riverside

Research Site, Farmington

Clearwater

Melbourne

Vero Beach

Augusta

Indianapolis

Jeffersonville

Edgewood

New Orleans

Shreveport

Auburn

Baltimore

Salisbury

Boston

Saint Charles

St Louis

Omaha

Albuquerque

Buffalo

East Syracuse

New York

Rochester

The Bronx

Williamsville

Burlington

Columbus

Oklahoma City

Flourtown

Philadelphia

Pittsburgh

Lincoln

Wakefield

Tyler

Salt Lake City

Chesapeake

Roanoke

Green Bay

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY